- Home
- MIRA vs CNFR Comparison
MIRA vs CNFR Comparison
Compare MIRA & CNFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- CNFR
- Stock Information
- Founded
- MIRA 2020
- CNFR 2009
- Country
- MIRA United States
- CNFR United States
- Employees
- MIRA N/A
- CNFR N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- CNFR Property-Casualty Insurers
- Sector
- MIRA Health Care
- CNFR Finance
- Exchange
- MIRA Nasdaq
- CNFR Nasdaq
- Market Cap
- MIRA 17.1M
- CNFR 14.9M
- IPO Year
- MIRA 2023
- CNFR 2015
- Fundamental
- Price
- MIRA $1.47
- CNFR $1.19
- Analyst Decision
- MIRA Strong Buy
- CNFR
- Analyst Count
- MIRA 2
- CNFR 0
- Target Price
- MIRA $14.00
- CNFR N/A
- AVG Volume (30 Days)
- MIRA 3.6M
- CNFR 23.2K
- Earning Date
- MIRA 11-12-2024
- CNFR 11-13-2024
- Dividend Yield
- MIRA N/A
- CNFR N/A
- EPS Growth
- MIRA N/A
- CNFR N/A
- EPS
- MIRA N/A
- CNFR N/A
- Revenue
- MIRA N/A
- CNFR $96,847,000.00
- Revenue This Year
- MIRA N/A
- CNFR N/A
- Revenue Next Year
- MIRA N/A
- CNFR $7.00
- P/E Ratio
- MIRA N/A
- CNFR N/A
- Revenue Growth
- MIRA N/A
- CNFR N/A
- 52 Week Low
- MIRA $0.51
- CNFR $0.65
- 52 Week High
- MIRA $6.40
- CNFR $1.91
- Technical
- Relative Strength Index (RSI)
- MIRA 48.43
- CNFR 52.76
- Support Level
- MIRA $1.65
- CNFR $1.10
- Resistance Level
- MIRA $1.75
- CNFR $1.26
- Average True Range (ATR)
- MIRA 0.33
- CNFR 0.09
- MACD
- MIRA -0.03
- CNFR -0.00
- Stochastic Oscillator
- MIRA 13.01
- CNFR 39.13
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance company engaged in the sale of property and casualty insurance products. It is engaged in three classes of insurance businesses namely commercial lines, personal lines, and wholesale agency business. Within these three businesses, the company offers various insurance products and insurance agency services. The company views the commercial and personal lines segments as underwriting business. The wholesale agency business provides non-risk bearing revenue through commissions and policy fees. Its revenues are derived from premiums earned from insurance operations.